单疗法与结合疗法在肺炎患者中的结果差异:系统性审查
Pande A Permatananda1, Pande A Pandit2
1Department of Pharmacology, Faculty of Medicine and Health Science, Universitas Warmadewa, Bali, Indonesia - nayakasih@gmail.com.
抗生素单疗法和组合疗法表现出类似的肺炎结果. 然而,组合治疗可能会降低免疫功能低下患者和严重疾病患者的死亡率 (APACHE ≥15).
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 临床药房 临床药房
背景情况:
- 肺炎仍然是传染病死亡率的全球主要原因.
- 选择有效的抗微生物策略,特别是对多药耐药细菌的选择,是一个重大的临床挑战.
- 对肺炎的最佳抗生素治疗方案 (单疗法与联合疗法) 进行了讨论.
研究的目的:
- 在肺炎患者中系统地审查比较单疗法和联合抗生素治疗方案的证据.
- 调查不同治疗策略中影响死亡率的因素.
- 为临床决策提供有关肺炎管理的信息.
主要方法:
- 在PubMed,谷歌学者,Proquest和Cochrane数据库中进行了系统的文献搜索.
- 包括2014年至2024年间发表的文章;不包括评论论文,不完整的文章和重复的文章.
- 分析了涉及11个单中心研究中的11,513名患者的6篇相关文章.
主要成果:
- 该审查确定了六项相关研究,包括包括队列和随机对照试验在内的多种方法.
- 对11,513名患者的分析显示,单疗法和组合疗法组之间可比的整体死亡率和住院时间长度相似.
- 一个子集分析表明,在特定的患者群体中,组合治疗的死亡率趋势较低.
结论:
- 抗生素单疗法和组合疗法在肺炎死亡率和住院时间方面表现出类似的疗效.
- 组合疗法可以为免疫功能低下的患者和患有严重疾病 (APACHE评分≥15) 的患者提供生存益处.
- 进一步的研究可能会澄清不同肺炎患者群体的最佳抗生素策略.
更多相关视频
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
相关概念视频
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
